Keywords: پاسخ جزئی; CI; confidence interval; CR; complete response; DC; disease control; OS; overall survival; PD; progressive disease; PR; partial response; RECIST; Response Evaluation Criteria in Solid Tumors; SD; stable disease; STS; soft tissue sarcoma; TARE; transarteri
مقالات ISI پاسخ جزئی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پاسخ جزئی; CR; complete response; DEE; drug-eluting embolic; ÎPBV; change in median parenchymal blood volume; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors; PBV; parenchymal blood volume; PD; progressive disease; PR;
Keywords: پاسخ جزئی; metastatic breast cancer; MBC; lobaplatin and gemcitabine; GL; lobaplatin and vinorelbine; NL; cisplatin and gemcitabine; GP; cisplatin and vinorelbine; NP; progression-free survival; PFS; overall survival; OS; response rate; RR; platinum-based compounds;
Keywords: پاسخ جزئی; CI; confidence interval; CR; complete response; DEE; drug-eluting embolic; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors; PEG; polyethylene glycol; PR;
Keywords: پاسخ جزئی; AAA; acquired aplastic anemia; IBMF; inherited bone marrow failure; IST; immunosuppressive therapy; CSA; cyclosporine A; ATG; antithymocyte globulin; CR; complete response; PR; partial response; TA; telomerase activity; TRAP; Telomeric Repeat Amplificatio
Keywords: پاسخ جزئی; thrombocytopenia; platelets; immune therapy; autoimmune disease; 4R+3Dex; 4 infusions of rituximab and three 4-day cycles of dexamethasone; CR; Complete response; ITP; Idiopathic thrombocytopenic purpura; PR; Partial response;
Keywords: پاسخ جزئی; CR; complete response; DM; diabetes mellitus; NA; not available; NR; no response; PPP; palmoplantar pustulosis; PR; partial response; SAPHO; synovitis, acne, pustulosis, hyperostosis, and osteitis; TNF; tumor necrosis factor;
Keywords: پاسخ جزئی; angiofibromas; fibrous cephalic plaque; hypomelanotic macules; shagreen patch; sirolimus; treatment; tuberous sclerosis complex; ungual fibroma; CC; complete clearance; FAs; facial angiofibromas; FASI; Facial Angiofibroma Severity Index; FCP; fibrous ceph
Keywords: پاسخ جزئی; Bx1; biopsy 1; Bx2; biopsy 2; CR; complete response; FFPE; formalin-fixed paraffin-embedded; IPA; Ingenuity Pathway Analysis; LN; lupus nephritis; NR; no response; PR; partial response;
Keywords: پاسخ جزئی; High-speed electrical interconnects; Modulation; Partial response; Equalization; Error probability bounds;
Keywords: پاسخ جزئی; kidney; carcinoma; renal cell; neoplasm metastasis; interleukin-2; molecular targeted therapy; CR; complete response; ECOG; Eastern Cooperative Oncology Group; HDIL-2; high dose IL-2; IL-2; interleukin-2; mRCC; metastatic RCC; OS; overall survival; PD; pr
Keywords: پاسخ جزئی; AE; adverse event; AML; acute myeloid leukemia; APC; anaphase promoting complex; CLL; chronic lymphocytic leukemia; CPC; chromosomal passenger complex; CR; complete response; CRi; complete remission with incomplete blood count recovery; FDA; Food and Drug
Keywords: پاسخ جزئی; Local control; Spine radiosurgery; Spine surgery; Tumor; Wound infection; CT; Computed tomography; CTV; Clinical target volume; DRR; Digitally reconstructed radiograph; ESCC; Epidural spinal cord compression; IM; Infrared markers; MESCC; Metastatic epidur
Keywords: پاسخ جزئی; CI; confidence interval; CR; complete response; HNC; head and neck cancer; MW; microwave; PR; partial response; RF; radiofrequency; RT; radiation therapy;
Keywords: پاسخ جزئی; CR; complete response; CNR; contrast-to-noise ratio; GIST; gastrointestinal stromal tumor; PD; progressive disease; PDGFRA; platelet-derived growth factor receptor A; PET; positron-emission tomography; PFI; progression-free interval; PR; partial response;
Keywords: پاسخ جزئی; Advanced urothelial carcinoma; Complete response; Overall survival; Partial response; Progression-free survival; Salvage systemic therapy;
Keywords: پاسخ جزئی; BRAF; v-raf murine sarcoma viral oncogene homolog; MEK; MAP kinase-ERK kinase; KIT; V-KIT Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; CTLA-4; cytotoxic T-lymphocyte-associated antigen 4; PD-1/PD-L1; programmed death-1/ programmed death-1 li
Keywords: پاسخ جزئی; CR; complete response; FFPE; formalin-fixed, paraffin-embedded; HCC; hepatocellular carcinoma; qPCR; quantitative polymerase chain reaction; PR; partial response;
Keywords: پاسخ جزئی; BE; bland embolization; CI; confidence interval; GM-CSF; granulocyte-macrophage colony-stimulating factor; HR; hazard ratio; IL; interleukin; ORR; overall response rate; OS; overall survival; PFS; progression-free survival; PR; partial response; SD; sta
Keywords: پاسخ جزئی; AH; amyloid heavy chain; AL; amyloid light chain; ASCT; autologous stem cell transplant; ATTR; amyloid transthyretin; B-Dex; bortezomib and dexamethasone; BMDex; bortezomib plus melphalan and dexamethasone; BNP; brain natriuretic peptide; Bor; bortezomib;
Keywords: پاسخ جزئی; Nodal clearance; Overall survival; Partial response; Prognosis; Tumor burden
Keywords: پاسخ جزئی; clinical response; extramammary Paget disease of the vulva; imiquimod; tissue-sparing surgery; treatment of recurrences; CR; complete response; EMPD; extramammary Paget disease; PR; partial response;
Keywords: پاسخ جزئی; CR; complete response; EFS; event-free survival; LCR; local control rate; LFU; lost to follow-up; N; number of patients; ORR; overall response rate; OS; overall survival; PD; progressive disease; PNET; primitive neuroectodermal tumor; PR; partial response
Keywords: پاسخ جزئی; AE; adverse effect; APC; antigen-presenting cells; CI; confidence interval; CP; carboplatin and paclitaxel; CR; complete response; CTLA-4; cytotoxic T-lymphocyte-associated antigen-4; cuSCC; cutaneous squamous cell carcinoma; FDA; Food and Drug Administ
Keywords: پاسخ جزئی; AJCC; American Joint Committee on Cancer; BMI; body mass index; CR; complete response; CSS; cause-specific survival; EBV; Epstein-Barr virus; FFLF; freedom from local failure; FFDF; freedom from distant failure; GORTEC; Oncology and Radiotherapy Group for
Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines
Keywords: پاسخ جزئی; ADRs; adverse drug reactions; AMI; astragalus membranaceus injection; CNKI; China national knowledge infrastructure database; CBM; China biological medicine database; CR; complete response; CI; confidence interval; CTCAE 3.0; Common Terminology Criteria f
Long-Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naïve Prostate Cancer: 3-Year Open Label Followup Results
Keywords: پاسخ جزئی; prostatic neoplasms; prostate-specific antigen; MDV 3100; bone density; drug related side effects and adverse reactions; ADT; androgen deprivation therapy; AE; adverse event; bALP; bone alkaline phosphate; BMD; bone mineral density; CR; complete response;
Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer
Keywords: پاسخ جزئی; ALK; anaplastic lymphoma kinase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BSA; body surface area; Ccr; creatinine clearance; CI; confidence interval; CR; complete response; CTCAE; common terminology criteria for adverse events; DCR;
A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease
Keywords: پاسخ جزئی; ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; AE; acute exacerbation; AE-ILD; acute exacerbation of interstitial lung disease; NSCLC; non-small cell lung cancer; S-1; tegafur-gimeracil-oteracil potassium; CBDCA; carboplatin; RECIST;
Effects of Reduction in Tumor Burden on Survival in Epithelioid Malignant Pleural Mesothelioma
Keywords: پاسخ جزئی; CR; complete response; FDA; Food and Drug Administration; HR; hazard ratio; MPM; malignant pleural mesothelioma; mRECIST; modified pleural Response Evaluation Criteria in Solid Tumors; ORR; objective response rate; OS; overall survival; PD; progression of
High interlaboratory and interobserver agreement of somatostatin receptor immunohistochemical determination and correlation with response to somatostatin analogs
Keywords: پاسخ جزئی; SSTR; somatostatin receptor; NEN; neuroendocrine neoplasms; SRS; somatostatin receptor scintigraphy; GI; gastrointestinal; GEP; gastroenteropancreatic; NET; neuroendocrine tumor; NEC; neuroendocrine carcinoma; PR; partial response; SD; stable disease; PD;
Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy
Keywords: پاسخ جزئی; AE; adverse event; ALK; anaplastic lymphoma kinase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; CR; complete response; ECOG; Eastern Cooperative Oncology Group; EGFR; epidermal growth factor receptor; HR; hazar
Radiation Segmentectomy versus Selective Chemoembolization in the Treatment of Early-Stage Hepatocellular Carcinoma
Keywords: پاسخ جزئی; CI; confidence interval; CR; complete response; HCC; hepatocellular carcinoma; HR; hazard ratio; IQR; interquartile range; mRECIST; modified Response Evaluation Criteria In Solid Tumors; PR; partial response; PSM; propensity score matching; RS; radiation
Next generation sequencing reveals a novel ALK G1128A mutation resistant to crizotinib in an ALK-Rearranged NSCLC patient
Keywords: پاسخ جزئی; ALK; anaplastic lymphoma kinase; CT; computed tomography; E-BUS; endobronchial ultrasound; IHC; immunohistochemistry; MRI; magnetic resonance imaging; NGS; next-generation sequencing; NSCLC; non-small cell lung cancer; PD; progression of disease; PR; part
The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Before Prophylactic Cranial Irradiation in Limited-Stage Small-Cell Lung Cancer
Keywords: پاسخ جزئی; Chest x-ray; Computed tomography; Partial response; Positron emission tomography; Thoracic chemoradiation;
Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: Single centre experience from a large tertiary care teaching hospital in Southern India
Keywords: پاسخ جزئی; TA; Takayasu arteritis; ITAS 2010; Indian Takayasu activity score 2010; EMR; electronic medical records; ACR; American College of Rheumatology; TADS; Takayasu arteritis damage score; DEI.Tak; disease extent index-Takayasu arteritis; CR; complete response;
Biologics for pityriasis rubra pilaris treatment: A review of the literature
Keywords: پاسخ جزئی; anti-TNF agents; biologics; erythroderma; interleukin 12/23 inhibitors; interleukin 17 inhibitors; pityriasis rubra pilaris; retinoids; CR; complete response; IL; interleukin; TNF; tumor necrosis factor; MR; marked response; PR; partial response; PRP; pit
CT-response patterns and the role of CT-textural features in inoperable abdominal/retroperitoneal soft tissue sarcomas treated with trabectedin
Keywords: پاسخ جزئی; CI; ConfidenceInterval; CT; ComputedTomography; CTTA; CT-TexturalAnalysis; DCR; Disease Control Rate; DNA; DeoxyribonucleicAcid; FDG-PET; Fludeoxyglucose-Positron Emission Tomography; Fig.; Figure; GIST; Gastrointestinal Stromal Tumor; NGLD; MNeighboring
Induction chemoradiotherapy versus chemotherapy alone for superior sulcus lung cancer
Keywords: پاسخ جزئی; ASA; American Society of Anesthesiologists physical status classification system; cGy; centigray; Ch; chemotherapy only; CI; confidence interval; CRT; concurrent chemoradiotherapy; CR; complete response; CT; computed tomography; DFI; disease free interval
STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network
Keywords: پاسخ جزئی; AE; adverse event; AKT; acutely transforming retrovirus AKT8 in rodent T-cell lymphoma; CI; confidence interval; CR; complete response; GIST; gastrointestinal stromal tumors; JAK; Janus kinase; MAPK; mitogen-activated protein kinase; OS; overall survival;
Aidi injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A meta-analysis of 42 RCTs following the PRISMA guidelines
Keywords: پاسخ جزئی; NSCLC; non-small cell lung cancer; PBC; platinum-based chemotherapy; CR; complete response; PR; partial response; NC; no change; SD; stable disease; PD; progressive disease; ORR; objective response rate; DCR; Disease Control Rate; KPS; karnofsky performan
Bispecific antibodies for cancer therapy: A review
Keywords: پاسخ جزئی; ADCC; antibody-dependent cell-mediated cytotoxicity; AE; adverse events; ALL; acute lymphoblastic leukemia; ALP; alkaline phosphatase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; B-ALL; B-cell acute lymphoblastic leukemia; BiTES; Bi-sp
Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer
Keywords: پاسخ جزئی; GSTP1; glutathione S-transferase P1; PD; progressive disease; SD; stable disease; PR; partial response; CR; complete response; TSG101; tumour susceptibility gene 101 protein; BCa; breast cancer; microRNA; miRNA; DNA; deoxyribonucleic acid; HSP70; heat sho
Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib
Keywords: پاسخ جزئی; AFP; alpha fetoprotein; CI; confidence interval; DNA; deoxyribonucleic acid; EGF; epidermal growth factor; FGF; fibroblast growth factor; G-CSF; granulocyte colony-stimulating factor; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HR; hazard ratio
The Role of Dual-Phase Cone-Beam CT in Predicting Short-Term Response after Transarterial Chemoembolization for Hepatocellular Carcinoma
Keywords: پاسخ جزئی; CI; confidence interval; CR; complete response; HCC; hepatocellular carcinoma; HU; Hounsfield unit; mRECIST; modified Response Evaluation Criteria in Solid Tumors; PD; progressive disease; PR; partial response; ROI; region of interest; SD; stable disease;
Tumor Dose Response in Yttrium-90 Resin Microsphere Embolization for Neuroendocrine Liver Metastases: A Tumor-Specific Analysis with Dose Estimation Using SPECT-CT
Keywords: پاسخ جزئی; CR; complete response; HCC; hepatocellular carcinoma; LSF; lung shunt fraction; mRECIST; Modified Response Evaluation Criteria in Solid Tumors; NET; neuroendocrine tumor; PD; progressive disease; PR; partial response; SD; stable disease; SPECT; single pho
Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer - final results from the prospective German TLK cohort study
Keywords: پاسخ جزئی; ALK; Anaplastic Lymphoma Kinase; BMI; body mass index; CCI; Charlson Comorbidity Index; CI; confidence interval; CR; complete response; CRISP; clinical research platform into molecular testing, treatment and outcome of non-small cell lung carcinoma patien
Modified Response Evaluation Criteria in Solid Tumors and European Association for the Study of the Liver Criteria Using Delayed-Phase Imaging at an Early Time Point Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma following
Keywords: پاسخ جزئی; CR; complete response; EASL; European Association for the Study of the Liver; ICC; intrahepatic cholangiocarcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors; PD; progressive disease; PR; partial response; RECIST; Response Evaluation
Korean Multicenter Registry of Transcatheter Arterial Chemoembolization with Drug-Eluting Embolic Agents for Nodular Hepatocellular Carcinomas: Six-Month Outcome Analysis
Keywords: پاسخ جزئی; BCLC; Barcelona Clinic Liver Cancer; CR; complete response; DEE; drug-eluting embolic; ECOG; Eastern Cooperative Oncology Group; HCC; hepatocellular carcinoma; IDR; intrahepatic distant recurrence; LTP; local tumor progression; PFS; progression-free survi
Comparison of the Efficacy of Tenofovir Versus Tenofovir plus Entecavir in the Treatment of Chronic Hepatitis B in Patients With Poor Efficacy of Entecavir: A Systematic Review and Meta-analysis
Keywords: پاسخ جزئی; chronic hepatitis B; entecavir; entecavir resistance; partial response; tenofovir; tenofovir plus entecavir;